Type 2 & other diabetes

Prognostic impact of type 2 diabetes mellitus and coronary microvascular dysfunction in patients undergoing rotational atherectomy during PCI

Cardiovasc DiabetolPublished Retrospective cohort study

An erratum to this article was published (Cardiovasc Diabetol, 15 Sep 2025 ↗)

Main finding · MACEResult — go to the resultHazard ratio 5.61 95% CI 2.606–12.083

Authors' conclusion

This study reveals that both T2DM and CMD are associated with the risk of MACEs in RA patients during the PCI. Combing T2DM and CMD can further improve the accessibility to predict the risk of MACEs.

Study context

Population
Patients undergoing rotational atherectomy during PCI, 3 medical centers
Participants
452 patients
Exposure
DM vs non-DM; Coronary microvascular dysfunction (CMD) vs no CMD; DM + CMD vs others
Outcome
MACE: cardiac death, MI, target vessel revascularization and readmission for unstable angina
Follow-up
24 months
Methodological detailsmulticenter, observational
  • Multicenter
  • Observational

Main finding

MACE

Hazard ratio

5.61

95% CI 2.606–12.083

P < 0.001

By group

DM + CMD
HR 5.61 (95% CI 2.606–12.083); P < 0.001

As reported in the abstract

Observational data: associations, not effects.

Further findings

Outcomenon-DMDMP value
Post-PCI angio-IMRLower in non-DM17.40 (unspecified 13.86–21.34)18.53 (unspecified 14.63–23.01)P = 0.037

Original publication

Prognostic impact of type 2 diabetes mellitus and coronary microvascular dysfunction in patients undergoing rotational atherectomy during PCI. Cardiovasc Diabetol. Published 24 July 2025. doi:10.1186/s12933-025-02868-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.